Preventive Care
News
Psoriasis cardiovascular risk parallels type 2 diabetes
Key clinical point: Psoriasis patients have increased coronary artery calcium levels similar to those seen in type 2 diabetes patients, suggesting...
Conference Coverage
Maraviroc shows potential for HIV PrEP in women
DURBAN, SOUTH AFRICA – Maraviroc shows promise as an alternative to Truvada for HIV pre-exposure prophylaxis.
Conference Coverage
H. pylori’s relationship with gastric cancer? It’s complicated
Does eradicating Helicobacter pylori prevent gastric cancer? The answer is yes, sometimes, but it depends on where you live, and what other...
Conference Coverage
Proper treatment of herpes zoster ‘a work in progress’
In medical school you may have been taught that herpes zoster infection primarily impacts elderly patients, but the burden of disease is shifting...
News
Power morcellation dropped, abdominal hysterectomy increased after FDA warning
Key clinical point: Electric power morcellation declined after the FDA recommended against using the technique during hysterectomy. Major finding...
News
Breast density is key to appropriate screening intervals
Key clinical point: Breast density is a key factor in determining appropriate screening intervals for mammography after age 50. Major finding:...
Conference Coverage
Anal cancer in HIV-infected patients: to screen or not?
Commentary
Myth of the Month: Vaccinations in patients with Guillain-Barré syndrome
Is there good evidence for patients with a history of Guillain-Barré syndrome to avoid influenza vaccines or vaccinations in general?
News
Two-dose HPV vaccines at younger age are noninferior to standard three-dose vaccine
Two-dose HPV vaccines at ages 9-14 years were found to be no less effective than three-dose vaccines at 15-25 years of age.
News
U.S. to jump-start antibiotic resistance research
The CDC is providing $67 million to help U.S. health departments address antibiotic resistance and related patient-safety concerns.
Conference Coverage
Motivational interviewing for HPV vaccination well accepted by doctors
Nine months after motivational interviewing training, 72% of providers were still using the technique in HPV vaccine counseling.